Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
NRAS Q61
i
Other names:
NRAS1, HRAS1, N-Ras Protein Part 4, Neuroblastoma RAS Viral (V-Ras) Oncogene Homolog, NRAS, Neuroblastoma RAS Viral Oncogene Homolog, NRAS Proto-Oncogene, GTPase
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
4893
Related biomarkers:
Expression
Mutation
CNA
Others
‹
NRAS overexpression (4)
NRAS expression (1)
NRAS overexpression (4)
NRAS expression (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
NRAS Q61
Colorectal Cancer
NRAS Q61
Colorectal Cancer
cetuximab
Resistant: A1 - Approval
cetuximab
Resistant
:
A1
cetuximab
Resistant: A1 - Approval
cetuximab
Resistant
:
A1
NRAS Q61
Colorectal Cancer
NRAS Q61
Colorectal Cancer
panitumumab
Resistant: A1 - Approval
panitumumab
Resistant
:
A1
panitumumab
Resistant: A1 - Approval
panitumumab
Resistant
:
A1
NRAS Q61
Melanoma
NRAS Q61
Melanoma
vemurafenib
Resistant: C3 – Early Trials
vemurafenib
Resistant
:
C3
vemurafenib
Resistant: C3 – Early Trials
vemurafenib
Resistant
:
C3
NRAS Q61
Colorectal Cancer
NRAS Q61
Colorectal Cancer
binimetinib
Sensitive: C3 – Early Trials
binimetinib
Sensitive
:
C3
binimetinib
Sensitive: C3 – Early Trials
binimetinib
Sensitive
:
C3
NRAS Q61
Melanoma
NRAS Q61
Melanoma
HL-085
Sensitive: C3 – Early Trials
HL-085
Sensitive
:
C3
HL-085
Sensitive: C3 – Early Trials
HL-085
Sensitive
:
C3
NRAS Q61
Melanoma
NRAS Q61
Melanoma
PD-0325901 + BGB-3245
Sensitive: D – Preclinical
PD-0325901 + BGB-3245
Sensitive
:
D
PD-0325901 + BGB-3245
Sensitive: D – Preclinical
PD-0325901 + BGB-3245
Sensitive
:
D
NRAS Q61
Melanoma
NRAS Q61
Melanoma
PD-0325901 + BGB-283
Sensitive: D – Preclinical
PD-0325901 + BGB-283
Sensitive
:
D
PD-0325901 + BGB-283
Sensitive: D – Preclinical
PD-0325901 + BGB-283
Sensitive
:
D
NRAS Q61
Melanoma
NRAS Q61
Melanoma
sorafenib
Sensitive: D – Preclinical
sorafenib
Sensitive
:
D
sorafenib
Sensitive: D – Preclinical
sorafenib
Sensitive
:
D
NRAS Q61
Cholangiocarcinoma
NRAS Q61
Cholangiocarcinoma
NXP800
Sensitive: D – Preclinical
NXP800
Sensitive
:
D
NXP800
Sensitive: D – Preclinical
NXP800
Sensitive
:
D
NRAS Q61
Melanoma
NRAS Q61
Melanoma
cobimetinib + roflumilast
Sensitive: D – Preclinical
cobimetinib + roflumilast
Sensitive
:
D
cobimetinib + roflumilast
Sensitive: D – Preclinical
cobimetinib + roflumilast
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login